Professional Documents
Culture Documents
MSI in High Risk MDS:AML
MSI in High Risk MDS:AML
ASH Home Blood App Alerts RSS Institution: Vrije Universiteit Brussel, Bibliotheek Sign In Log out
search
Advanced Search
Advertisement
Current Issue First Edition Collections All Issues Abstracts Article Types Video Library
Microsatellite Instability (MSI) In High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid
Leukaemia (AML) Cells Promotes Frameshift Mutations In DNA Repair Genes: Indications for PARP
Inhibitor Therapy.
Terry J Gaymes, Azim Mohamedali, Austin G Kulasekararaj, Sydney Shall, and Ghulam J. Mufti
Abstract
Abstract 1194
http://www.bloodjournal.org/content/116/21/1194?sso-checked=true Page 1 of 3
Microsatellite Instability (MSI) In High Risk Myelodysplastic Syndro…pair Genes: Indications for PARP Inhibitor Therapy. | Blood Journal 10/05/2018, 09*34
nucleotides that are misincorporated during DNA replication and not removed by the .
○ Article
mismatch repair pathway. Using fluorescent PCR analysis, PI sensitive cell lines, P39, .
○ Info & Metrics
KG-1 and Molm-13 showed MSI-high (instability at ≥ 2 loci) at 5 mononucleotide .
○ e-Letters
microsatellites, in contrast to 12 PI insensitive cell lines that showed no MSI at these
loci. We also show using fluorescent PCR and DNA sequencing that these MSI
, Related Articles
positive cell lines demonstrate MSI (monoallelic 1–2 base pair [bp] deletion) in the
No related articles found.
coding region microsatellites of DNA repair genes, Ataxia telancgiectasia mutated
gene (ATM), CTiP, and MRE11. Monoallelic 1–2 bp base pair deletions at these loci
produced frameshift mutations that induced aberrant gene splicing transcripts in
ATM and MRE11 and a markedly truncated CTiP gene transcript. No MSI was
detected in DNA repair genes CHK1, RAD50, PTEN, BLM and ATR in these cell lines
and no mutations were observed at any DNA repair gene microsatellite in the 13 PI
insensitive cell lines. We then determined MSI in high risk MDS patients with or
without monosomy 7 (-7/del7q). 13 of 63 (21%) high risk MDS patients showed MSI
(9 MSI-low and 4 MSI-high). Of the 13 MSI positive patients, 7 (4 MSI-high, 3 MSI-
low) had monosomy 7 and other complex chromosomal abnormalities (Group 1,
54%), 2 (MSI-low) patients had isolated monosomy 7 (Group 2, 15%) whilst 4
patients (MSI-low) had normal cytogenetics (Group 3, 30%). Constitutional DNA from
these patients did not show MSI at these loci. Significantly, however, Group 3 with
MSI and normal cytogenetics all had widespread UPD and cryptic chromosome
changes determined by SNPA. Strikingly, thus all 13 patients with MSI possessed
chromosomal abnormalities, both gross and cryptic. Furthermore, 12 patients (19%)
found to be cytogenetically normal and lacking UPD and genomic aberrations by
SNPA did not show MSI. We have also identified that 3 patients with MSI-high (Group
1) and 1 patient with MSI-low (Group 3) had a monoallelic 1 bp deletion in the CTiP
exon coding microsatellite. 1 bp deletion within the coding exon of CTiP resulted in
an abbreviated CTiP gene transcript. In conclusion, we have made the important
correlation between MSI and subsequent frameshift mutations in specific DNA repair
genes with the gross and cryptic chromosomal changes observed in MDS/AML.
Identification of a cohort of MDS/AML patients with MSI would herald a significant
advancement for the selection of candidates for PI therapy.
http://www.bloodjournal.org/content/116/21/1194?sso-checked=true Page 2 of 3
Microsatellite Instability (MSI) In High Risk Myelodysplastic Syndro…pair Genes: Indications for PARP Inhibitor Therapy. | Blood Journal 10/05/2018, 09*34
Powered by
○ Previous
/ Back to top
Advertisement
ASH Home Research Education Advocacy Meetings Publications ASH Store Blood Journals ( ) * +
Copyright © 2018 by American Society of Hematology Privacy Policy Terms of Service Contact Us
http://www.bloodjournal.org/content/116/21/1194?sso-checked=true Page 3 of 3